These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Aligos Therapeutics (ALGS) delivered earnings and revenue surprises of -78.53% and 51.62%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock ...

Familial hypertension can be genetic, meaning you can get a gene from a parent that increases your risk of developing high blood pressure. You may also be more prone to developing high blood pressure ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for the fourth quarter and year-end 2024 and provided a business update. “2024 ...

We wrap up our coverage of the markets and the week. We sell different types of products and services to both investment professionals and individual investors. These products and services are ...

LIVMARLI has received orphan designation for ALGS and PFIC. LIVMARLI is currently being evaluated ... a PDE4D inhibitor for the treatment of Fragile X syndrome, a rare genetic neurocognitive disorder.

Yet the Greenland shark seems to defy this pattern, meaning it must have evolved genetic tools to stave off age-related diseases. Recently, scientists have gotten some new genetic clues to their ...

The ALGS Year 4 Finals had a massive turnout, with the incredibly popular Battle Royale taking over Tokyo for one of the biggest esports events of the year. What’s more, news about Apex Legends ...

Inc.’s stock price changed recently Upgrades and downgrades for ALGS from analysts ALGS’s stock price momentum as measured by its relative strength Before we jump into Aligos Therapeutics, Inc.’s ...

Scientists suggest genetics played a big role – and they say the evolution of this singular ability was key to our survival. A new study links a particular gene to the ancient origins of spoken ...

Despite single nucleotide variant‐based genome‐wide association studies improving our understanding of the genetics of CAD, the contribution of structural variants (SVs) to the risk of CAD remains ...